(Q43742898)

English

A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections

scientific article published in May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

invasive fungal infections

1 reference

based on heuristic

inferred from title

author name string

Deniz Yilmaz

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Can Balkan

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Yilmaz Ay

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Mehmet Akin

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Bulent Karapinar

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Kaan Kavakli

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

234-242

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Recent developments in the management of invasive fungal infections in patients with hematological malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Aspergillosis in children with cancer: A 34-year experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Invasive aspergillosis in a paediatric haematology department: a 15-year review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Voriconazole in the treatment of invasive mold infections in transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Advances in antifungal therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Successful antifungal combination therapy with voriconazole and caspofungin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: A 13-year experience at a single Italian institution

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Fungal Infections in Children With Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Assessing risk factors for systemic fungal infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Second-line treatment in invasive mould infections.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Voriconazole plasma monitoring.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2009.01808.X

21 January 2018

Identifiers

10.1111/J.1439-0507.2009.01808.X

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43742898&oldid=2102977494"